Thursday, January 05, 2006

FDA clears Axxent Electronic Brachytherapy System for breast cancer

United Press International, January 4, 2006
The Axxent system uses non-radioactive sources to deliver radiation treatment, which eliminates the need for heavily shielded environments and may enable the therapy to be used in more clinical settings. "This may accelerate patient choice of breast sparing lumpectomy surgery with adjuvant radiation therapy over the alternative of a full mastectomy," Xoft said in a statement. "However, as important as the clinical benefits are, the true breakthrough may relate to easy and convenient access to non-radioactive brachytherapy for women who today opt for mastectomy or lumpectomy without radiation therapy," Dowlat added. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */